Related Experiment Video

Updated: Aug 21, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Ets1 is an effector of protein kinase Calpha in cancer cells

Martina Vetter1, Sibylle G Blumenthal, Ralph K Lindemann

  • 1Universität Halle-Wittenberg, Universitätsklinik und Poliklinik für Gynäkologie, Ernst-Grube-Str. 40, 06097 Halle (Saale), Germany.

Oncogene
|November 9, 2004
PubMed

Insights

Protein kinase C alpha (PKCalpha) regulates Ets1 protein levels and stability in cancer cells. This interaction is crucial for cellular responses to certain drugs and UV light, suggesting Ets1 acts as a PKCalpha effector.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Protein kinase C alpha (PKCalpha) and Ets1 are implicated in breast cancer progression.
  • Previous research suggests a potential functional interaction between PKCalpha and Ets1.

Purpose of the Study:

  • To investigate the functional relationship between PKCalpha and Ets1 in cancer cells.
  • To elucidate the mechanisms by which PKCalpha influences Ets1 expression and function.

Main Methods:

  • RNA interference (siPalpha) to attenuate PKCalpha expression.
  • Pulse-chase experiments and proteasome inhibitor treatment to assess Ets1 synthesis and stability.
  • Comparison of cellular responses using specific siRNAs for PKCalpha (siPalpha) and Ets1 (siE1).
  • Microarray analysis to evaluate gene expression changes.

Main Results:

  • PKCalpha depletion reduced Ets1 protein expression, affecting both synthesis and stability.
  • Calcium/calmodulin-dependent kinase II (CaMKII) inhibition partially reversed the effect of PKCalpha depletion on Ets1.
  • ERK1/2 kinases were not involved in PKCalpha-mediated Ets1 regulation.
  • Both siPalpha and siE1 similarly impacted cellular responses to mithramycin A and UV light.
  • Microarray data indicated shared gene expression changes regulated by PKCalpha and Ets1.

Conclusions:

  • Ets1 functions as an effector for PKCalpha in mediating specific cellular functions in cancer cells.
  • The PKCalpha-Ets1 pathway plays a role in cellular responses to chemotherapeutic agents and DNA damage.
  • Targeting the PKCalpha-Ets1 interaction may offer therapeutic strategies for breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...